Vital Therapies Expands SILVER Trial to Saudi Arabia

Bioartificial Human Liver Therapy Trial Progressing SAN DIEGO , June 8 /PRNewswire/ -- Vital Therapies, Inc., (VTI) is pleased to announce that the first two subjects have been enrolled at King's College Hospital in London in the expansion of its SILVER ( S tabilization I n L i VER failure)

Pivotal ELAD Study in United States and Europe

Vital new hope for Liver failure

Vital Therapies Plans Phase III Trials for September

Liver device helps man survive until transplant

Doctors test latest attempt at artificial liver

Program Expands on Successful Results from prior U.S., U.K. and China Trials

Boston, MA., Nov. 7, 2007 /PRNewswire/- /- Vital Therapies, Inc. (VTI), announced today data from two studies of the company’s ELAD® (Extracorporeal Liver Assist Device) System were presented at the 2007 American Association for the Study of Liver Diseases (AASLD) Annual Meeting, which